STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Houlihan Lokey insider sale notice: 40,000 shares planned on NYSE

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Houlihan Lokey (HLI) submitted a Form 144 notifying the proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,997,848.00 and an approximate sale date of 08/27/2025. The shares were acquired as restricted stock vesting under a registered plan: 20,016 shares vested on 05/15/2023 and 19,984 shares vested on 05/15/2024, with payment described as services rendered. The filer reports no sales in the past three months and affirms no undisclosed material adverse information.

Positive

  • None.

Negative

  • Planned sale of 40,000 common shares representing an aggregate market value of $7,997,848.00 scheduled for 08/27/2025
  • Insufficient filer identity/relationship details in the provided content, limiting ability to assess insider status or governance implications

Insights

TL;DR Officer/affiliate intends to sell 40,000 vested restricted shares valued near $8.0M; routine Rule 144 notice, limited immediate informational impact.

This Form 144 documents a planned Rule 144 sale of restricted shares that vested under a registered plan. The filing shows the shares were acquired via compensation (services rendered) in two vesting events in 2023 and 2024. The sale is routed through Morgan Stanley Smith Barney on the NYSE and is scheduled for 08/27/2025. The filing contains no disclosure of insider identity or additional context about motivation. For investors, the filing confirms an insider liquidity event but does not by itself indicate operational or financial deterioration.

TL;DR This is a compliance disclosure of a planned insider sale under Rule 144; governance implications are routine absent further details.

The Form 144 satisfies regulatory requirements by reporting the number of shares, acquisition dates, nature of acquisition (restricted stock vesting), broker details, and the approximate sale date. The statement that there were no securities sold in the past three months and the signer27s attestation regarding material non-public information are standard. Because the filing omits the filer27s name/relationship in the provided content, stakeholders cannot assess insider status or evaluate potential governance signaling beyond the sale itself.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for HLI disclose?

The filing discloses a proposed sale of 40,000 HLI common shares through Morgan Stanley Smith Barney, aggregate value $7,997,848.00, approx. sale date 08/27/2025.

How were the HLI shares to be sold acquired?

The shares were acquired as restricted stock vesting under a registered plan: 20,016 vested on 05/15/2023 and 19,984 vested on 05/15/2024, consideration listed as services rendered.

Did the filer report any HLI sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker and exchange are involved in the proposed HLI sale?

The broker is Morgan Stanley Smith Barney LLC and the planned transaction is listed for the NYSE.

Does the Form 144 assert the filer possesses undisclosed material information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Houlihan Lokey Inc

NYSE:HLI

HLI Rankings

HLI Latest News

HLI Latest SEC Filings

HLI Stock Data

12.27B
54.44M
0.13%
103.13%
1.21%
Capital Markets
Investment Advice
Link
United States
LOS ANGELES